Neurosarcoidosis

Current Treatment Options in Neurology

Volumn 9, Issue 3, 2007, Pages 161-168

  Patel, Ashok V ^b   Stickler, David E ^b   Tyor, William R ^a  

^a RALPH H JOHNSON VA MEDICAL CENTER   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ALCOHOL; AMPHOTERICIN B; AZATHIOPRINE; CHLORAMBUCIL; CHLORAMPHENICOL; CHLOROQUINE; CHOLINERGIC RECEPTOR BLOCKING AGENT; CYCLOPHOSPHAMIDE; CYCLOSPORIN; ESTROGEN; FOLIC ACID; FOLIC ACID DERIVATIVE; GENTAMICIN; GLUCOCORTICOID; HYDROXYCHLOROQUINE; INFLIXIMAB; METHOTREXATE; METHYLPREDNISOLONE; NONSTEROID ANTIINFLAMMATORY AGENT; PHENOBARBITAL; PREDNISONE; RANITIDINE; RIFAMPICIN; SULFAMETHOXAZOLE; SUXAMETHONIUM; TETRACYCLINE; TOBRAMYCIN; TRIMETHOPRIM; VANCOMYCIN;

ACNE; ADIPOSE TISSUE; ADRENAL SUPPRESSION; ALOPECIA; ANAPHYLAXIS; ANEMIA; ANOREXIA; ARTHRALGIA; ASEPTIC NECROSIS; BONE MARROW SUPPRESSION; CANCER RISK; CATARACT; CENTRAL NERVOUS SYSTEM DISEASE; CLINICAL EVALUATION; COMBINATION CHEMOTHERAPY; CONFUSION; CONGESTIVE HEART FAILURE; COUGHING; DIARRHEA; DISEASE EXACERBATION; DRUG COST; DRUG DOSE INCREASE; DRUG DOSE REDUCTION; DRUG ERUPTION; DRUG FEVER; DRUG HYPERSENSITIVITY; DRUG MEGADOSE; DRUG RESPONSE; DRUG SUBSTITUTION; DRUG WITHDRAWAL; ELECTROCARDIOGRAM; EOSINOPHILIA; FEVER; FLACCID PARALYSIS; FLUID RETENTION; GASTRITIS; HALLUCINATION; HEADACHE; HEARING IMPAIRMENT; HEART ARRHYTHMIA; HIRSUTISM; HUMAN; HYDROCEPHALUS; HYPERGLYCEMIA; HYPERTENSION; HYPOKALEMIA; INFECTION; INFECTION RISK; INFERTILITY; INSOMNIA; INTERSTITIAL PNEUMONIA; INTRAOCULAR HYPERTENSION; KIDNEY DYSFUNCTION; LEUKEMIA; LEUKOPENIA; LICHEN PLANUS; LIPOMATOSIS; LIVER CIRRHOSIS; LIVER FIBROSIS; LIVER TOXICITY; LOW DRUG DOSE; LUNG FIBROSIS; LYMPHOCYTOPENIA; LYMPHOMA; MENTAL INSTABILITY; MONOTHERAPY; MUSCLE CRAMP; MUSCLE WEAKNESS; MYALGIA; MYOPATHY; NAUSEA; NEPHROTOXICITY; NIGHT BLINDNESS; OSTEOPOROSIS; OUTCOME ASSESSMENT; PANCYTOPENIA; PARESTHESIA; PERIPHERAL NEUROPATHY; PSYCHOSIS; RASH; RELAPSE; RETINA INJURY; REVIEW; SARCOIDOSIS; SEIZURE; SIDE EFFECT; SKIN; STOMACH PAIN; TASTE DISORDER; THERAPY RESISTANCE; THROMBOCYTOPENIA; TINNITUS; TREATMENT DURATION; TREMOR; VOMITING; WEIGHT GAIN;

EID: 34248384802     PISSN: 10928480     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02938405     Document Type: Review

References (40)

1. Mayer S, Yim G, Onesti S, et al.: Biopsy-proven isolated sarcoid meningitis. J Neurosurg 1993, 78:994-996.
2. Agbogu B, Stern B, Sewell C, et al.: Therapeutic considerations in patients with refractory neurosarcoidosis. Arch Neurol 1995, 52:875-879.
3. Scott T: Neurosarcoidosis: progress and clinical aspects. Neurology 1993, 43:8-12.
4. Chapelon-Abric C, de Zuttere D, Duhaut P, et al.: Cardiac sarcoidosis - a retrospective study of 41 cases. Medicine (Baltimore) 2004, 83:315-334.
5. Delaney P: Neurologic manifestations in sarcoidosis. Ann Intern Med 1977, 87:336-345.
6. Vourlekis J, Sawyer R, Newman L: Sarcoidosis: developments in etiology, immunology and therapeutics. Adv Intern Med 2000, 45:209-257.
7. McGrath D, Daniil Z, Foley B, et al.: Epidemiology of familial sarcoidosis in the UK. Thorax 2000, 55:751-754.
8. Hoitsma E, Faber G, Dent M, et al.: Neurosarcoidosis: a clinical dilemma. Lancet Neurol 2004, 3:397-407.
9. Stern B: Neurosarcoidosis. Neurol Chron 1992, 2:1-6.
10. Constantino T, Digre K, Zimmerman P: Neuro-ophthalmic complications of sarcoidosis. Semin Neurol 2000, 20:123-137.
11. Castellano-Sanchez A: Extensive leptomeningeal and intraparenchymatous spinal cord neurosarcoidosis. South Med J 2000, 93:815-817.
12. Zajicek J, Scolding N, Foster O, et al.: Central nervous system sarcoidosis - diagnosis and management. Q J Med 1999, 92:103-117.
13. Marangoni S, Argentiero V, Tavolato B: Neurosarcoidosis: clinical description of 7 cases with a proposal for a new diagnostic strategy. J Neurol 2006, 253:488-495.
14. Dumas J, Valeyre D, Chapelon-Abric C, et al.: Central nervous system sarcoidosis: follow-up at MRI during steroid therapy. Radiology 2000, 214:411-420.
15. Handler M, Johnson L, Dick A, et al.: Neurosarcoidosis with unusual MRI findings. Neuroradiology 1993, 35:146-148.
16. Borucki S, Nguyen B, Ladoulis C, et al.: Cerebrospinal fluid immunoglobulin abnormalities in neurosarcoidosis. Arch Neurol 1989, 46:270-273.
17. Oksanen V, Fyhrquist F, Somer H, et al.: Angiotensin-converting enzyme in cerebral fluid. Neurology 1985, 35:1220-1223.
18. Dale J, O'Brien J: Determination of angiotension-converting enzyme levels in cerebrospinal fluid is not a useful test for the diagnosis of neurosarcoidosis. Mayo Clin Proc 1999, 74:535.
19. Stern B, Griffin D, Luke R, et al.: Neurosarcoidosis cerebro-spinal fluid lymphocyte subpopulations. Neurology 1987, 37:878-881.
20. Hoitsma E, Marziniak M, Faber CG, et al.: Small fiber neuropathy in sarcoidosis. Lancet 2002, 359:2085-2086.
21. Reed L, Abbas S, Markivee C, et al.: Neurosarcoidosis responding to steroids. AJR Am J Roentgenol 1986, 146:819-821.
22. Baughman R, Winger D, Lower E: Methotrexate is steroid sparing in acute sarcoidosis: results of a double blind, randomized trial. Sarcoidosis Vasc Diffuse Lung Dis 2000, 17:60-66.
23. Doty J, Mazur J, Judson M: Treatment of corticosteroid-resistant neurosarcoidosis with a short-course cyclophosphamide regimen. Chest 2003, 124:2023-2026.
24. Weiner H, Mackin G, Orav E, et al.: Intermittent cyclo-phosphamide pulse therapy in progressive multiple sclerosis: final report of the Northeast Cooperative Multiple Sclerosis Treatment Group. Neurology 1993, 43:910-918.
25. Boumpas D, Yamada H, Patronas N, et al.: Pulse cyclophosphamide for severe neuropsychiatric lupus. Q J Med 1991, 81:975-984.
26. Stern B, Schonfeld A, Sewell C, et al.: The treatment of neurosarcoidosis with cyclosporine. Arch Neurol 1992, 49:1063-1072.
27. Bielory L, Holland C, Gascon P, et al.: Uveitis, cutaneous and neurosarcoid: treatment with low-dose cyclosporine A. Transplant Proc 1988, 20:144-148.
28. Doty J, Mazur J, Judson M: Treatment of neurosarcoidosis with infliximib. Chest 2005, 127:1064-1071.
29. Pettersen J, Zochodne D, Bell B, et al.: Refractory neurosarcoidosis responding to infliximib. Neurology 2002, 59:1660-1661.
30. Sollberger M, Fluri F, Baumann T, et al.: Successful treatment of steroid-refractory neurosarcoidosis with infliximab. J Neurol 2004, 251:760-761.
31. Katz J, Bruno M, Winterkorn J, et al.: The pathogenesis and treatment of optic disc swelling in neurosarcoidosis: a unique therapeutic response to infliximib. Arch Neurol 2003, 60:426-430.
32. Carter J, Valeriano J, Vasey F, et al.: Refractory neuro-sarcoidosis: a dramatic response to infliximib. Am J Med 2004, 117:277-279.
33. Sharma O: Effectiveness of chloroquine and hydroxyl-chloroquine in treating selected patients with sarcoidosis with neurological involvement. Arch Neurol 1998, 55:1248-1254.
34. Bruns F, Pruemer B, Haverkamp U, et al.: Neurosarcoidosis: an unusual indication for radiotherapy. Br J Radiol 2004, 77:777-779.
35. Bejar I, Kerby G, Ziegler D, et al.: Treatment of central nervous system sarcoidosis with radiotherapy. Ann Neurol 1985, 18:258-260.
36. Menninger M, Amdur R, Marcus R Jr: Role of radiotherapy in the treatment of neurosarcoidosis. Am J Clin Oncol 2003, 26:e115-e118.
37. Kingsley D, Kendall B: CT of the adverse effects of therapeutic radiation of the central nervous system. AJNR Am J Neuroradiol 1981, 2:453-460.
38. Fried E, Landau A, Sher J, et al.: Spinal cord sarcoidosis: a case report and review of the literature. J Assoc Acad Minor Phys 1993, 4:132-137.
39. Hesselmann V, Wedekind C, Terstegge K, et al.: An isolated fourth ventricle in neurosarcoidosis: MRI findings. Eur Radiol 2002, 12:S1-S3.
40. Foley K, Howell J, Junck L: Progression of hydrocephalus during corticosteroid therapy for neurosarcoidosis. Postgrad Med J 1989, 65:481-484.